Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Prepaid Assets (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Prepaid Assets for 4 consecutive years, with $5.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets fell 37.19% to $5.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.0 million, a 37.19% decrease, with the full-year FY2024 number at $4.8 million, up 11.82% from a year prior.
  • Prepaid Assets was $5.0 million for Q3 2025 at Century Therapeutics, up from $4.3 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $7.9 million in Q3 2024 to a low of $46000.0 in Q3 2023.
  • A 4-year average of $4.6 million and a median of $4.6 million in 2022 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: soared 17067.39% in 2024, then crashed 42.16% in 2025.
  • Century Therapeutics' Prepaid Assets stood at $110000.0 in 2022, then skyrocketed by 3769.09% to $4.3 million in 2023, then grew by 11.82% to $4.8 million in 2024, then increased by 4.22% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Prepaid Assets are $5.0 million (Q3 2025), $4.3 million (Q2 2025), and $4.5 million (Q1 2025).